article thumbnail

Why The Health Care Reform Debate Makes Me Sick

The Recovering Engineer

As I look at the health care reform debate, I see a number of these behaviors in the way the discussion(s) is (are) proceeding. I am not a doctor, pharmacist, attorney, drug company executive or any other person who has deep insights into the intricacies of our health care system. And, frankly, it makes me sick.

article thumbnail

Why The Health Care Reform Debate Makes Me Sick

The Recovering Engineer

As I look at the health care reform debate, I see a number of these behaviors in the way the discussion(s) is (are) proceeding. I am not a doctor, pharmacist, attorney, drug company executive or any other person who has deep insights into the intricacies of our health care system. And, frankly, it makes me sick.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Searching for Health Care's Entrepreneurial Spirit

Harvard Business Review

Editor's note: This post is part of a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. At first blush, it would appear that entrepreneurship is alive and well in health care.

article thumbnail

The Company Outsmarting Big Pharma in Africa

Harvard Business Review

Downstream, it works closely with local distributors to reach widely disparate health care facilities, pharmacies, and other distribution channels, such as a production and marketing partnership with Medpro in South Africa and a minority stake in Quality Chemical Associates in Uganda. to develop and produce an improved first?line

Company 12
article thumbnail

Big Pharma's Hidden Business Model and How Your Company Funds It

Harvard Business Review

The study assembles considerable evidence about the hidden business model of major pharmaceutical companies: to devote most of their research budget to developing hundreds of drugs that provide few if any advantages over existing drugs and then market them heavily to doctors and patients. See The Risks of Prescription Drugs (Columbia 2010).

article thumbnail

Offices Can Be Bastions of Civility in an Uncivil Time

Harvard Business Review

Since 2010 Weber Shandwick and Powell Tate, in partnership with KRC Research, have tracked Americans’ perceptions of civility in various aspects of life, including work. Pharmaceutical company Lilly has said , “Many tragic world events have shaken our employees, making it difficult for them to bring their full selves to work.

article thumbnail

To Control Health Care Costs, U.S. Employers Should Form Purchasing Alliances

Harvard Business Review

When it comes to health care costs, America’s employers are at a crossroads. That means that to control costs going forward, employers may have to confront the true underlying causes of rising health care expenditures: high prices and health care inefficiencies. The Future of Health Care.